Agios Pharmaceuticals Inc (AGIO.O)

AGIO.O on Nasdaq

119.62USD
19 Dec 2014
Price Change (% chg)

$-0.10 (-0.08%)
Prev Close
$119.72
Open
$120.90
Day's High
$120.90
Day's Low
$117.04
Volume
1,932,916
Avg. Vol
996,018
52-wk High
$124.39
52-wk Low
$21.40

AGIO.O

Chart for AGIO.O

About

Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is intend to apply its deep understanding of metabolism, coupled with the Company’s ability to create medicines that can inhibit or activate metabolic enzymes, to fundamentally change the way cancer and inborn errors of metabolism (IEMs) are treated. The... (more)

Overall

Beta: --
Market Cap (Mil.): $3,927.36
Shares Outstanding (Mil.): 36.63
Dividend: --
Yield (%): --

Financials

  AGIO.O Industry Sector
P/E (TTM): -- 151.53 38.61
EPS (TTM): -1.49 -- --
ROI: -18.85 -0.59 18.27
ROE: -27.14 -1.72 19.14
Search Stocks

Competitors

  Price Change
Pfizer Inc. (PFE.N) $31.42 -0.03
Novartis AG (NOVN.VX) CHF92.35 -1.20
Roche Holding Ltd. (ROG.VX) CHF270.40 -18.30
Sanofi SA (SASY.PA) €74.99 -0.65
AstraZeneca plc (AZN.L) 4,555.50p +39.00
GlaxoSmithKline plc (GSK.L) 1,385.00p 0.00
Eli Lilly and Co (LLY.N) $70.16 +0.42
Shire PLC (SHP.L) 4,470.00p -63.00
Shire PLC (3159084.L) -- --
Alexion Pharmaceuticals, Inc. (ALXN.OQ) $181.96 +3.09

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks